Search results
Eli Lilly: Positive results on its new Alzheimer's drug
Yahoo Finance· 1 year agoEli Lilly (LLY) reported positive results for its Alzheimer's drug, donanemab, and plans to file for...
Eli Lilly says its new Alzheimer's drug can stop the disease's progression
Quartz via Yahoo! Philippines News· 1 year agoAmerican drugmaker Eli Lilly has some good news about its experimental Alzheimer’s treatment,...
Exclusive-Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs
Reuters via Yahoo! Philippines News· 1 year agoEli Lilly and Co expects the U.S. Medicare health plan to back down from strict coverage limits on...
Drug CEO: How the industry is fighting to sway impact of Texas abortion pill ruling
Yahoo Finance· 1 year agoThe battle brewing over the Texas abortion pill ruling was not something the drug industry...
FDA’s approval of Friedreich’s ataxia drug is a game changer for treatment of rare diseases
Quartz via Yahoo! Philippines News· 1 year agoA drug to treat a rare neurological disorder has only had to jump through one hoop—read: clinical...
Inflation in January was both hot and cold: Morning Brief
Yahoo Finance· 1 year agoThis article first appeared in the Morning Brief. Get the Morning Brief sent directly to your inbox...
Inflation data will test 'disinflation' optimism: What to know this week
Yahoo Finance· 1 year agoA busy economic calendar in the week ahead will have investors focused on signs inflation is — or...
Medical experts divided on whether 2nd FDA-approved Alzheimer's drug provides a benefit
Yahoo News· 1 year agoThe FDA recently approved a drug that may help patients in the early stages of Alzheimer’s by...
Stock market news live updates: Stocks end first week of 2023 higher after jobs report spurs big...
Yahoo Finance· 2 years agoU.S. stocks staged their first notable rally of 2023 to close the week higher Friday after December...
Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus
Reuters via Yahoo! Philippines News· 2 years agoSAN FRANCISCO (Reuters) -An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive...